Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,changeToInventory,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,market,currency,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,marketState,exchange,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,shortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,TN8.DE,-4596000000,393028000,320000000,,2753000000,,2337000000,1808000000,5217000000,3089000000,3089000000,,-118000000,,,,416000000,9906000000,6817000000,4689000000,-336000000,,2337000000,2337000000,12831000000,15684000000,30873000000,35058000000,1413000000,65931000000,438000000,1423000000,30350000000,5228000000,26823000000,-11414000000,2457000000,5583000000,6995000000,4000000,-2562000000,6133000000,17685000000,2000000,6337000000,18650000000,4342000000,2146000000,0.0,-1998000000.0,-2804000000.0,-4850000000.0,-1321000000.0,20000000.0,-4733000000.0,-2000000000.0,137000000.0,1978000000.0,621000000.0,-32000000.0,-87000000.0,21000000.0,341000000.0,-628000000.0,,,10690000000,en-US,US,EQUITY,False,Delayed Quote,de_market,EUR,0.15887006,0,REGULAR,GER,False,False,473.6,1630566624,1.6000061,476.0,476.0,473.6,27,5.3094172,15,Europe/Berlin,CEST,2,0.33898434,473.6 - 476.0,472.0,473.0,474.8,finmb_97023,XETRA,Thermo Fisher Scientific Inc.,USD,364,326,433.31,10.754778,40.29 - 479.1,-5.5,-0.011479858,40.29,479.1,1619676008,1634646600,1635165000,0.92,28.446154,0.0019491526,16.649,7200000,89.2,457.11716,16.48285,0.03605826,408.67395,64.926056,186773159936,THERMO FISH.SCIENTIF.DL 1,0.76,,,479.1,40.29,457.12,408.67,364,326,393.03M,,392.25M,0.21%,89.88%,,,,,,0.88,0.20%,0.92,0.19%,,1.31%,,"Sep 14, 2021",,,"Dec 31, 2020","Apr 03, 2021",22.08%,27.91%,10.05%,24.91%,35.89B,90.81,59.00%,16.01B,12.39B,7.92B,16.65,196.60%,5.58B,14.2,18.65B,53.21,2.53,89.20,9.91B,6.53B,Value,02451,Healthcare,80000,3,7,"Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.",Waltham,781 622 1000,MA,5,1609372800,1625097600,9,United States,http://www.thermofisher.com,86400,6,168 Third Avenue,Diagnostics & Research
t-1,TN8.DE,-4219000000,393028000,376000000,,2892000000,,2498000000,2096000000,5557000000,3085000000,3085000000,,-132000000,,,,394000000,10550000000,7465000000,4993000000,-193000000,,2498000000,2498000000,12685000000,15579000000,34545000000,34507000000,1478000000,69052000000,437000000,1131000000,28116000000,4462000000,26041000000,-9625000000,1629000000,10325000000,10304000000,2628000000,-2807000000,6687000000,21957000000,53000000,6472000000,19153000000,4029000000,2175000000,279000000.0,-626000000.0,-1000000.0,-49000000.0,359000000.0,40000000.0,2766000000.0,-2000000000.0,102000000.0,3339000000.0,602000000.0,-6000000.0,-87000000.0,-1000000.0,126000000.0,-586000000.0,-81000000.0,-444000000.0,11653000000,en-US,US,EQUITY,False,Delayed Quote,de_market,EUR,0.15887006,0,REGULAR,GER,False,False,473.6,1630566624,1.6000061,476.0,476.0,473.6,27,5.3094172,15,Europe/Berlin,CEST,2,0.33898434,473.6 - 476.0,472.0,473.0,474.8,finmb_97023,XETRA,Thermo Fisher Scientific Inc.,USD,364,326,433.31,10.754778,40.29 - 479.1,-5.5,-0.011479858,40.29,479.1,1619676008,1634646600,1635165000,0.92,28.446154,0.0019491526,16.649,7200000,89.2,457.11716,16.48285,0.03605826,408.67395,64.926056,186773159936,THERMO FISH.SCIENTIF.DL 1,0.76,,,479.1,40.29,457.12,408.67,364,326,393.03M,,392.25M,0.21%,89.88%,,,,,,0.88,0.20%,0.92,0.19%,,1.31%,,"Sep 14, 2021",,,"Dec 31, 2020","Apr 03, 2021",22.08%,27.91%,10.05%,24.91%,35.89B,90.81,59.00%,16.01B,12.39B,7.92B,16.65,196.60%,5.58B,14.2,18.65B,53.21,2.53,89.20,9.91B,6.53B,Value,02451,Healthcare,80000,3,7,"Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.",Waltham,781 622 1000,MA,5,1609372800,1625097600,9,United States,http://www.thermofisher.com,86400,6,168 Third Avenue,Diagnostics & Research
t-2,TN8.DE,-6828000000,393028000,296000000,,2252000000,,1933000000,1647000000,4332000000,2389000000,2389000000,,-149000000,,,,319000000,8521000000,6132000000,4189000000,-137000000,,1933000000,1933000000,12870000000,15467000000,32237000000,31824000000,1222000000,64061000000,437000000,982000000,25705000000,4904000000,25782000000,-9785000000,1956000000,7540000000,6228000000,2000000,-2970000000,5180000000,18234000000,39000000,5883000000,21105000000,3829000000,1703000000,277000000.0,-365000000.0,-710000000.0,-791000000.0,730000000.0,31000000.0,1733000000.0,-2000000000.0,181000000.0,2708000000.0,575000000.0,-6000000.0,-87000000.0,-25000000.0,-26000000.0,-366000000.0,-118000000.0,-663000000.0,12006000000,en-US,US,EQUITY,False,Delayed Quote,de_market,EUR,0.15887006,0,REGULAR,GER,False,False,473.6,1630566624,1.6000061,476.0,476.0,473.6,27,5.3094172,15,Europe/Berlin,CEST,2,0.33898434,473.6 - 476.0,472.0,473.0,474.8,finmb_97023,XETRA,Thermo Fisher Scientific Inc.,USD,364,326,433.31,10.754778,40.29 - 479.1,-5.5,-0.011479858,40.29,479.1,1619676008,1634646600,1635165000,0.92,28.446154,0.0019491526,16.649,7200000,89.2,457.11716,16.48285,0.03605826,408.67395,64.926056,186773159936,THERMO FISH.SCIENTIF.DL 1,0.76,,,479.1,40.29,457.12,408.67,364,326,393.03M,,392.25M,0.21%,89.88%,,,,,,0.88,0.20%,0.92,0.19%,,1.31%,,"Sep 14, 2021",,,"Dec 31, 2020","Apr 03, 2021",22.08%,27.91%,10.05%,24.91%,35.89B,90.81,59.00%,16.01B,12.39B,7.92B,16.65,196.60%,5.58B,14.2,18.65B,53.21,2.53,89.20,9.91B,6.53B,Value,02451,Healthcare,80000,3,7,"Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.",Waltham,781 622 1000,MA,5,1609372800,1625097600,9,United States,http://www.thermofisher.com,86400,6,168 Third Avenue,Diagnostics & Research
t-3,TN8.DE,-8995000000,393028000,264000000,,1253000000,,1156000000,1668000000,3379000000,1447000000,1447000000,,-139000000,,,,97000000,6917000000,5470000000,3538000000,-194000000,,1156000000,1156000000,13170000000,15334000000,31718000000,29875000000,1146000000,61593000000,436000000,1145000000,23860000000,5034000000,25700000000,-9755000000,1997000000,5818000000,6013000000,675000000,-2989000000,4887000000,15775000000,64000000,5164000000,20671000000,3648000000,1385000000,-256000000.0,-259000000.0,1213000000.0,1180000000.0,742000000.0,77000000.0,2827000000.0,-2000000000.0,20000000.0,1886000000.0,574000000.0,7000000.0,-87000000.0,-23000000.0,-185000000.0,-269000000.0,-168000000.0,23000000.0,9762000000,en-US,US,EQUITY,False,Delayed Quote,de_market,EUR,0.15887006,0,REGULAR,GER,False,False,473.6,1630566624,1.6000061,476.0,476.0,473.6,27,5.3094172,15,Europe/Berlin,CEST,2,0.33898434,473.6 - 476.0,472.0,473.0,474.8,finmb_97023,XETRA,Thermo Fisher Scientific Inc.,USD,364,326,433.31,10.754778,40.29 - 479.1,-5.5,-0.011479858,40.29,479.1,1619676008,1634646600,1635165000,0.92,28.446154,0.0019491526,16.649,7200000,89.2,457.11716,16.48285,0.03605826,408.67395,64.926056,186773159936,THERMO FISH.SCIENTIF.DL 1,0.76,,,479.1,40.29,457.12,408.67,364,326,393.03M,,392.25M,0.21%,89.88%,,,,,,0.88,0.20%,0.92,0.19%,,1.31%,,"Sep 14, 2021",,,"Dec 31, 2020","Apr 03, 2021",22.08%,27.91%,10.05%,24.91%,35.89B,90.81,59.00%,16.01B,12.39B,7.92B,16.65,196.60%,5.58B,14.2,18.65B,53.21,2.53,89.20,9.91B,6.53B,Value,02451,Healthcare,80000,3,7,"Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.",Waltham,781 622 1000,MA,5,1609372800,1625097600,9,United States,http://www.thermofisher.com,86400,6,168 Third Avenue,Diagnostics & Research
